U.S. President Joe Biden on Saturday came one step closer to his first major political victory: passage of his coronavirus economic relief package.What is it? A $1.9 trillion bill that Democrats said would help the country defeat the coronavirus and repair the economy. Republicans say it is more expensive than necessary. The measure follows five earlier virus bills totaling about $4 trillion that Congress has enacted since last spring.What is the latest? The Senate approved the pandemic relief package over Republican opposition Saturday by a party-line vote of 50-49.What’s next? The Senate made several changes to the bill, which was passed earlier by the U.S. House. Now the bill returns to the House for final passage, which could come early next week.How does it fight the pandemic? The bill contains about $14 billion to help distribute vaccines faster and get shots into arms quicker. It also provides $46 billion to expand federal, state and local testing, and enhance contact tracing.What’s in it for jobless Americans? It would extend the expanded unemployment benefits from the federal government through September 6 at $300 a week. The first $10,200 of jobless benefits would be nontaxable for households with incomes of less than $150,000.What about health care? It would provide a 100% subsidy of COBRA health insurance premiums through September so that laid-off workers can remain on their employer health plans. It also would increase subsidies for insurance through the Affordable Care Act through the end of 2022.Will there be subsidy checks? Yes, a direct payment of $1,400 for a single taxpayer, or $2,800 for a married couple who file jointly, plus $1,400 per dependent. Individuals earning up to $75,000 would get the full amount, as would married couples with incomes up to $150,000. The size of the check would shrink as incomes rise, with a hard cutoff at $80,000 for individuals and $160,000 for married couples.What about schools? The bill calls for about $130 billion in additional help to schools for students in kindergarten through 12th grade. The money would be used to modify classrooms to allow more social distancing, install ventilation systems and buy personal protective equipment. The money could also be used to increase the hiring of nurses and counselors and to provide summer school.Will businesses receive help? It offers $25 billion in a new program aimed at restaurants and bars hurt by the pandemic. It also has $7.25 billion for the Paycheck Protection Program, and it allows more nonprofits to apply for loans that are designed to help borrowers meet their payroll and operating costs and can potentially be forgiven.Can it help renters and homeowners? It provides about $30 billion to help pay the rent and utilities for low-income households and people who are unemployed, and to provide vouchers and other support for people who are homeless. States and tribes would receive an additional $10 billion for homeowners who are struggling with mortgage payments because of the pandemic.  
…

Pharmaceutical giant Merck and an American laboratory announced progress Saturday in the design of an oral drug against COVID-19. Their antiviral has shown positive effects in reducing the viral load in current tests.”Knowing that there is an unmet need for antiviral therapy for SARS-CoV-2, we are encouraged by these preliminary results,” Wendy Painter, chief drug officer at Ridgeback Biotherapeutics, said in a statement.Merck interrupted its work on two potential COVID-19 vaccines at the end of January but continues its research on two treatments against the disease, including molnupiravir, developed with the American company Ridgeback Bio.The drug significantly reduced the viral load in patients after five days of treatment, the company said Saturday in a meeting with infectious-disease specialists.Phase 2a of the test — the trials have three phases before possible marketing — was carried out on 202 out-of-hospital patients who had COVID-19 with symptoms. There was no alert in terms of safety, and “of the four serious incidents reported, none was considered in connection with the drug studied,” the laboratory said.Influenza drugs like oseltamivir (Tamiflu) and zanamivir (Relenza) are sometimes prescribed for seasonal flu, but research is struggling to find an antiviral for COVID-19.The results of this study, “namely a more rapid decrease in the viral load in individuals with COVID-19 in the initial phase and who have received molnupiravir, are promising,” assured William Fischer, one of the directors of the study and professor of medicine at the University of North Carolina.”If they are reinforced by additional studies, they could have important consequences in terms of public health, as the virus continues to spread and evolve in the world.”Merck is also working on a treatment called MK-711. The first results of clinical trials show a reduction of more than 50% in the risk of death or respiratory failure in hospitalized patients with moderate to severe forms of COVID-19, the group said at the end of January.  
…

Johns Hopkins Coronavirus Resource Center has recorded more than 116 million global coronavirus cases. The U.S. is on the verge of having 30 million infections, followed by India with 11 million and Brazil with 10.8 million.Earlier this week, Brazilian President Jair Bolsonaro had callous words for fellow Brazilians unhappy with the president’s response to the pandemic.“Stop all this fussing and whining,” the president said. “How long are you going to keep on crying?” Bolsonaro was speaking in the Brazilian state of Goiás, where almost 9,000 people have died.Only the U.S. has more COVID deaths than Brazil. According to Hopkins, the U.S. has more than 522,000 COVID deaths, while Brazil has reported more than 262,000.Russia’s statistics agency said Friday more than 200,000 Russians diagnosed with COVID-19 have died, more than double the figure used by the government’s coronavirus task force.The figures released Friday from Rosstat, a government agency that releases coronavirus data infrequently, said it had recorded 200,432 deaths through January. Those figures include nearly 70,000 people who had the virus at the time of death, but whose main cause of death was not deemed to be COVID-19.The tally is significantly more the government’s coronavirus task force’s data, which had recorded 88,285 deaths as of Friday. The government’s task force does not count deaths in which the virus was present but is not ruled the main cause.Using the figures from Rosstat, Russia would have the third most COVID-19 fatalities in the world, behind only the United States and Brazil.Rosstat also reported Friday that Russia has recorded 394,000 more deaths since the start of the pandemic until the end of January than in the previous period — suggesting that coronavirus-related deaths in the country could be even higher.In another development Friday, the World Health Organization said investigators who conducted an inspection in China to determine origins of the COVID-19 virus would release a report on their findings in mid-March.Peter Ben Embarek, who led the mission, clarified at a regular coronavirus news briefing Friday in Geneva that an interim report would not be released as previously reported.“To clarify, there was never a plan for an interim report, first of all,” Embarek said. “It was hoped we would get a summary report out,” but “the director-general [Tedros Adhanom Ghebreyesus] will receive that report from the team in the near future and we will discuss the recommendations.”The Wall Street Journal reported Thursday the WHO team decided not to release its interim account “amid mounting tensions between Beijing and Washington.”Another international group of scientists has called for the WHO to conduct a new inquiry into the origins of COVID-19. The scientists calling for a new probe said in an open letter Thursday that the WHO team “did not have the mandate, the independence, or the necessary accesses to carry out a full and unrestricted investigation.”The scientists also noted in their letter that the WHO investigators in China were accompanied by their Chinese counterparts.The first cases of COVID-19 were reported in the Chinese city of Wuhan in December 2019.Throughout his term, former U.S. president Donald Trump strongly suggested, without evidence, the coronavirus leaked from a Wuhan laboratory.A global team of inspectors began its four-week investigation in Wuhan in January and finished it last month.Italy on Friday surpassed 3 million confirmed coronavirus cases since the pandemic began. The health ministry reported 24,036 new confirmed cases Friday, the third straight day this week that daily new caseloads exceeded 20,000 cases.The government said it would further tighten coronavirus restrictions in three of its 20 regions after health officials warned of the increase of cases of more contagious variants.France reported 23,507 new confirmed COVID-19 cases on Friday, which is down from the previous week, however officials said the number of people in intensive care with COVID-19 reached its highest level this year.Canada’s drug regulator announced Friday that it had approved Johnson & Johnson’s COVID-19 vaccine, the fourth such inoculation to get approval. Canada has also approved vaccines from Pfizer-BioNTech, Moderna and AstraZeneca.Mickey Mouse may once again scamper on Disneyland’s streets, according to California officials who said Friday the state’s theme and amusement parks could open as early as April 1.There are, of course, COVID-19 restrictions on the openings. The parks would open under restricted capacity. They would also have to be in a county that is not under certain constraints, designed to slow the coronavirus transmission rate.A purple county has the most restrictions due to its coronavirus rate of infection, under California’s color-code system. Disneyland is in a purple country, but at the present rate of transmission, officials expect the theme park would likely be eligible for reopening sometime in April.
…

For more than a century, International Women’s Day has celebrated women’s achievements across the globe, overcoming persistent gender inequality. This year’s observance comes as the UN reports women, particularly women of color, face especially high rates of unemployment. VOA’s Esha Sarai has more.
Camera: Karen Sánchez and Rebaz Majeed
…

One year into the COVID-19 pandemic in Kenya, thousands of families are struggling with deepening poverty and unemployment.  A survey by the charity Twaweza shows 60% of Kenyan families can no longer afford three meals per day.  Brenda Mulinya reports from Nairobi.
Camera: Amos Wangwa       Producer: Henry Hernandez
…

The White House COVID-19 response team said Friday that all coronavirus vaccines currently available were safe and effective and urged Americans to take whichever one they had access to, after the mayor of Detroit reportedly declined an allocation of the Johnson & Johnson drug.At a news briefing Thursday, Detroit Mayor Mike Duggan said he was declining a shipment of the Johnson & Johnson vaccine, adding that while it was a very good vaccine, he felt the Pfizer-BioNTech and Moderna vaccines were better and he wanted to get the people of Detroit “the best.”At a virtual news briefing Friday, coronavirus special adviser Andy Slavitt said that the White House reached out to the mayor and that there had been a misunderstanding. It was not Duggan’s intent to refuse the vaccine, said Slavitt, adding, “In fact, he is very eager for the Johnson & Johnson vaccine.”National Institutes of Health infectious-disease expert Dr. Anthony Fauci again said that all three approved vaccines were “extraordinarily” effective in preventing severe disease and death. He advised taking the first available vaccine because the important thing is to be vaccinated.Meanwhile, Centers for Disease Control Director Dr. Rochelle Walensky said the agency hoped to release its official guidance for people who have been fully vaccinated. She said she understood people were eager to know what they could and couldn’t do, but that the centers wanted to make sure to get the advice right.The CDC guidelines would address a myriad of questions regarding approved activities, such as wearing a mask, flying on an airplane, or patronizing a bar or restaurant.More than 54 million people in the U.S. have received at least one shot; more than 27 million Americans are fully vaccinated.  
…

The World Health Organization says it is using every measure it has to curb the spread of parallel Ebola outbreaks in Guinea and the Democratic Republic of Congo. One of the biggest lessons learned from the 2014-2016 Ebola epidemic in West Africa — the largest in history — is the critical importance of acting quickly to contain the deadly disease.  World health officials began marshaling staff and working on a strategy to combat the disease as soon as the first cases of the Ebola virus were detected in Guinea on February 14. A rapid assessment conducted by the WHO in the country and in the region found the risk level to be very high. WHO Representative in Guinea, Georges Alfred Ki-Zerbo, said the WHO and partners have been stepping up efforts to implement Guinea’s Strategic response plan. FILE – Health workers from the Guinean Ministry of Health prepare forms to register medical staff ahead of their anti-Ebola vaccines at the N’zerekore Hospital, Feb. 24, 2021.That, he said, involves increased surveillance on the ground, accelerating preparedness measures in neighboring countries, and working closely with communities to interrupt the outbreak as soon as possible. “In doing so, we are engaging traditional healers, including also traditional practitioners, and we are going into communities to discuss with them, to listen to them and see what is the understanding of the disease, what is the fears and the preoccupation of the communities so that we can increase the success of our interventions,” Ki-Zerbo said. To date, the WHO reports 18 cases of Ebola in Guinea, including four deaths. Ki-Zerbo said health workers have traced hundreds of people who have come in contact with infected people. So far, he ssaid, more than 1,600 people have been vaccinated against the virus, including high-risk contacts and health workers. Meanwhile, North Kivu province in eastern Congo is experiencing its own fresh Ebola outbreak. Since February 7, the WHO reports there have been 11 cases and four deaths. Another Ebola outbreak in eastern Congo ended just last June. WHO director of strategic health operations, Michel Yao, said dealing with both the COVID-19 and Ebola epidemics is a challenge, especially in countries with fragile health systems. “There are some similar approaches, at least, in some of the components like community isolation, as well as the preventive measures that have to be implemented,” Yao said. “Vaccination is maybe less challenging because this works in different areas. And I think the approach in most of the countries, as with COVID, they will probably start with health workers.” WHO health officials agree it will likely be difficult to get the funding needed to stem the twin Ebola outbreaks. Besides appealing to government donors, they said they also will tap leading financial institutions such as the World Bank, the African Development Bank and the U.S. Agency for International Development. 
 
…

The east-central African nation of Rwanda began its COVID-19 vaccination program Friday, using the Pfizer-BioNTech vaccine, making it the first African nation to administer the drug. The nation received 102,960 doses of Pfizer-BioNTech and 240,000 doses of AstraZeneca through the international vaccine cooperative, COVAX facility earlier this week. Rwandan health authorities began transporting both shots around the hilly nation of 12 million people using helicopters to reach far-flung areas.  Earlier this week, Minister of Health Dr. Daniel Ngamije said the nation’s vaccination plan would prioritize high-risk groups first, including the sick and the elderly, as well as front-line medical workers. He said the government’s goal was to vaccinate 30% of Rwandans by the end of 2021, and 60% by the end of 2022. The government of Rwandan President Paul Kagame, which prides itself on efficiency and technological prowess but is often criticized as authoritarian, has installed special infrastructure to keep the Pfizer vaccine at the recommended -80 to -60 Celsius. Last week, after examining research conducted by its manufacturers, the U.S. Food and Drug Administration ruled the Pfizer-BioNTech vaccine, when transported and stored at conventional refrigerator temperatures, can still be effective for up to two weeks. 
 
…

A U.S. and a Japanese astronaut ventured out of the International Space Station (ISS) Friday, in the second of two spacewalks conducted this week to complete upgrades and repairs to the orbiting outpost.
 
NASA Flight Engineer Kate Rubins and Japan Aerospace Exploration Agency (JAXA) astronaut Soichi Noguchi, have a number of tasks on their agenda, including venting ammonia from the Early Ammonia System and complete installing support frames for new, high-efficiency solar panels, a project begun during a spacewalk Sunday.
 
Friday’s spacewalk is the fourth for both Rubins and Noguchi in their astronaut careers, and the 236th in the ISS’s 20-year history.
 
…

A Wall Street Journal report says World Health Organization investigators who recently visited China to determine the origins of the emergence of the COVID-19 virus will not release a promised interim report of their findings.The Journal account, published Thursday, said the WHO team decided not to release its interim account “amid mounting tensions between Beijing and Washington.” Another international group of scientists has called for the WHO to conduct a new inquiry into COVID’s origins.The scientists calling for a new probe said in an open letter Thursday that the WHO team “did not have the mandate, the independence, or the necessary accesses to carry out a full and unrestricted investigation.”The scientists also noted in their letter that the WHO investigators in China were joined by their Chinese counterparts.A report in The Guardian says hospitals in Papua New Guinea have run out of money and are “shutting their doors” because of an uptick in COVID-19 cases. The country had registered 124 new coronavirus cases in all of February but had 108 new infections by March 4.The U.S. Food and Drug Administration issued a public warning Thursday about thermal imaging devices or scanners used by many businesses to measure elevated temperature, a COVID symptom.The FDA alert said, “improper use of the systems may provide inaccurate temperature readings due to a variety of factors.” The agency also said it has sent “several Warning Letters” to companies that are “offering unapproved, uncleared, and unauthorized thermal imaging systems for sale.Auckland, New Zealand, is set to ease its seven-day lockdown on Sunday, moving from alert level three to alert level two because no new community coronavirus cases were recorded Friday. The rest of the country is scheduled to move to alert level one Sunday.Johns Hopkins Coronavirus Resource Center said early Friday there are more than 115 million global COVID cases. The U.S. remains at the top of the list with almost 29 million infections, followed by India with 11 million and Brazil with 10.7 million.
…

Confidence in COVID-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on Friday.Co-led by Imperial College London’s Institute of Global Health Innovation (IGHI) and the polling firm YouGov, the survey found trust in COVID-19 vaccines had risen in nine out of 14 countries covered, including France, Japan and Singapore, which had previously had low levels of confidence.The latest update of the survey, which ran from Feb. 8-21, found that people in Britain are the most willing, with 77% saying they would take a vaccine designed to protect against COVID-19 if one was available that week.This is up from 55% in November, shortly before the first COVID-19 vaccine — co-developed by Pfizer- BioNTech — gained regulatory approval for use in Britain.People in France, Singapore and Japan remained among the least willing to have a COVID-19 vaccine, at 40%, 48% and 48%, respectively, but all three have seen confidence rising since November when only 25%, 36% and 39% of people were positive.The survey also found that worries over vaccine side effects have faded in the majority of countries, with fewer than half (45%) of all respondents currently reporting concern.Again, people in France, Singapore and Japan are currently most worried about side effects, with around six in 10 feeling concerned (56%, 59%, 61%), while Britain is the least concerned.The latest survey involved more than 13,500 people in Australia, Britain, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Norway, Singapore, South Korea, Spain and Sweden.
…

Astronauts aboard the International Space Station this week built the bones for much-needed power upgrades.  Also, SpaceX took flight with and without success, and flaming space junk lights up Australian skies.  VOA’s Arash Arabasadi brings us the Week in Space.
…

Women’s rights activists in Kenya have welcomed U.S. President Joe Biden’s order revoking the ban blocking U.S. funding to women’s health organizations that provide abortion or abortion-related services. Critics say the so-called gag rule left women uninformed about safe options to end a pregnancy.  
   
Forty-five-year-old Najma Wangoi lost her sister in 2018 after she bought medicine from a drug store to induce an abortion and it led to her death.   
 
The mother of two says her sister didn’t know there was a better way to end a pregnancy.  
     
“She didn’t know because she bought those medicines for 3,500 shillings ($35). If she knew there was a place to do a safe abortion, she would still be alive. She should have explained her situation to the hospital, and she would have been treated,” Wangoi said.
     
Under the global gag rule, originally enacted by U.S. President Ronald Reagan and revived by President Donald Trump, it became difficult for millions of women to seek abortion services at health centers receiving U.S. funds.    
 
The gag rule blocked U.S. government funding for organizations if they provided abortion services, counseling or referrals.   
 
The rule effectively shut down health clinics, as well as community sensitization programs about sexual and reproductive health.  
 
Boniface Ushie, researcher with the African Population and Health Research Center, says while the ban has now been lifted by U.S. President Joe Biden, it will not be enough to undo the effects it had on women’s health in Africa.  
   
“Lifting it is great, but it’s going to take a while for the impact of the global gag rule as instituted by Trump to begin to lift. So, it’s going to require a lot of funding. It’s going to require a lot of programs to undo what has been done over the past four years,” Ushie said.
 
Thirty-three-year-old Rose Akoth said she is lucky to be alive after taking tablets to abort a baby in 2019. After three days of pain, the fetus emerged but the placenta got stuck in her womb, requiring urgent medical attention.   
 
“I have a health problem now since I did the abortion because it didn’t come out well. These days my menstruation goes for a month and there is nothing I am using like family planning. My menstrual period goes on non-stop,” she said.  
   
Akoth, Wangoi and others hope that with the gag rule lifted, more women can be saved from abortion-related deaths and health crises.  
  
…

The World Health Organization’s Europe director reported Thursday that new COVID-19 cases rose 9% to just over a million in the region last week.  
 
Hans Kluge said it was the first increase in new infections after six weeks of decline.
 
At a virtual news briefing from his headquarters in Copenhagen, Kluge told reporters that more than half the region saw increases in new cases.
 
Kluge said most of the resurgence was seen in central and eastern Europe, although new cases were also on the rise in several western European countries where rates were already high.  
 
 “Over a year into the pandemic, our health systems should not be in this situation. We need to get back to the basics,” he said.
 
He said the high rates of transmission and rapid spread of variants require increased vigilance, improved testing and isolation of cases, tracing and quarantining contacts, and care.  
 
Kluge said the so-called British variant has been reported in 43 of 53 countries in the region; the South African variant in 26 countries; and the variant originally identified in Brazil and Japan in 15 countries.  
 
The WHO Europe chief urged nations to accelerate the rollout of vaccines, saying they are already saving lives, with hospitalizations and deaths in most at-risk groups declining significantly.  
 
Kluge said 45 countries have started vaccinations in the European region.
 
He also called on leaders to reengage with their communities to counter “pandemic fatigue” to prevent people from putting aside preventative measures.
…

The World Health Organization says COVID-19 vaccine distribution in African countries is accelerating and hopeful signs are emerging that a significant proportion of Africa’s population will be covered by the end of the year. Latest figures put the number of infections in Africa at more than 3.9 million, with 104,000 deaths.Data show the COVID-19 pandemic overall is on a downward trend in most countries on the continent. However, World Health Organization officials fear a resurgence of cases in the future as pressure increases to ease lockdown restrictions. They point to a recent rise of COVID-19 cases in 10 countries as a worrying sign.At the same time, the acceleration of vaccine distribution in Africa is giving rise to hope. WHO Regional Director for Africa Matshidiso Moeti said nearly 10 million vaccine doses have been delivered to 11 countries this week and she expects about half of all countries on the continent will receive COVID-19 vaccine deliveries in the coming weeks.She said most countries will have vaccination programs underway by the end of March. Moeti said the COVAX facility is targeting three percent of the population as it starts its vaccine rollout across Africa. But, she added, COVAX aims to increase that figure and cover 20 percent of the population by the end of the year.“We are very pleased that the African Union, working through its acquisition, vaccine acquisition task team has targeted ensuring that by the end of the year, sufficient vaccine has been procured and available to countries to cover 60 percent of the population,” she said.By the end of the year, Moeti said she hopes to reach a level of coverage in African countries that not only reduces severe illness and deaths but also starts to slow down the spread of the coronavirus.In other words, she said she hopes the continent will achieve so-called herd immunity. 
…

Nearly 50 countries have either received or ordered at least one of the three Chinese-developed COVID-19 vaccines, according to an Associated Press survey. More with VOA’s Mariama Diallo on the vaccine rollouts.
…

U.S. President Joe Biden, while expressing frustration, has limited power to overrule decisions by state governors who are ending mask mandates and lifting other restrictions amid the coronavirus pandemic.”I think it’s a big mistake,” Biden told a small group of reporters Wednesday in the Oval Office when asked about Republican governors in Texas and Mississippi casting off restrictions and allowing businesses to reopen at full capacity.As the nation makes progress with vaccinations, “the last thing we need is the Neanderthal thinking that in the meantime, ‘Everything’s fine. Take off your mask. Forget it,’ ” added the president, a Democrat. “It still matters.”During the previous administration of Republican President Donald Trump, who downplayed the severity of COVID-19 despite eventually becoming infected himself, not wearing a mask became a political statement.Since taking office in January, Biden and top federal health officials repeatedly have emphasized mask wearing and social distancing while the country escalates the number of Americans being vaccinated against the virus.He noted during Wednesday’s brief interaction with reporters that he carries a card with the updated number of people in the country who have died because of the coronavirus.“As of yesterday, we had lost 511,874 Americans. We’re going to lose thousands more,” said Biden. “We’ll not have everybody vaccinated until sometime in the summer.”The president, urging people to frequently wash their hands, wear masks and maintain social distancing, added, “And I know you all know that I wish the heck some of our elected officials knew it.”FILE – In this image from video, CDC Director Dr. Rochelle Walensky speaks during a briefing on the Biden administration’s response to the COVID-19 pandemic, Jan. 27, 2021, in Washington.Earlier Wednesday, Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention (CDC), said that “now is not the time” to lift COVID-19 restrictions.” Her comment came a day after Texas Governor Greg Abbott declared his state “100% open.”Texas, the second most populous state in the country, ranks 47th out of 50 for COVID-19 vaccinations per capita.At a virtual news briefing for the White House COVID-19 response,  Walensky said the next month or two would be pivotal in deciding the trajectory of the pandemic.While infection rates across the country have been leveling off, COVID-19 variants such as the highly transmissible so-called British strain are poised to surge, threatening to destroy what progress has been made, Walensky said.FILE – Mississippi Gov. Tate Reeves signs legislation at the Governor’s Mansion in Jackson, June 30, 2020.In Mississippi on Tuesday, Governor Tate Reeves followed Texas’ move and lifted his state’s mask mandate and business restrictions.Under the U.S. Constitution and because of Supreme Court decisions, states — not the federal government — have primary authority to control the spread of dangerous diseases within their jurisdictions.“A federalist system means that the central government, the United States government, is a government of limited powers, and the states retain police powers, which historically has included public health,” explained Meryl Chertoff, an adjunct professor of law at Georgetown University in Washington.The Commerce Clause, which gives Congress exclusive authority to regulate interstate and foreign commerce, does allow the federal government to order quarantines and impose other health measures to prevent the spread of diseases from foreign countries, as well as between states. But that authority has never been affirmed by the courts, according to the American Bar Association.A year ago, at the start of the pandemic, Trump said he had discussed “a national lockdown” with advisers to minimize the spread of the coronavirus. Several days later, he dismissed the idea.“I think it was a political decision to leave these decisions to the governors in order to be able to allocate praise and blame,” Chertoff, the executive director of the Georgetown Project on State and Local Government Policy and Law, told VOA.Some authorities desired a powerful federal response, but an unprecedented executive order would likely have been challenged in the courts on constitutional grounds.FILE – Tenants’ rights advocates march from the Edward W. Brooke Courthouse, Jan. 13, 2021, in Boston. The protest called on the then-incoming Biden administration to extend the eviction moratorium initiated in response to the COVID-19 pandemic.Courts are currently considering the constitutionality of evictions amid the pandemic, which had been ordered halted by the CDC, a federal agency.“This is relevant to the mask mandates because it suggests that the courts are now starting to consider whether under provisions of the Public Health Services Act of 1944 … the authority of the federal government to act with respect to emergency public health situations is broader than has been previously acknowledged,” said Chertoff.She cautioned that those who want the president and the executive branch to have “a more muscular set of tools” to deal with an unprecedented public health crisis need to consider that once the federal government has such tools, “they will be around not just for the next four years, but for the next 40 years.”   
…